Nir Drayman
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- interferon and immune responses
Papers in
-
- Herpesvirus Infections and Treatments 7
- Cytomegalovirus and herpesvirus research 5
- Oncology 7
- Polyomavirus and related diseases 5
- Co-authors
- Ariella Oppenheim (8 shared papers)Savaş Tay (8 shared papers)Luke F. Vistain (2 shared papers)Veronika Butin‐Israeli (3 shared papers)Oren Kobiler (4 shared papers)Ofer Mandelboim (2 shared papers)Yoav Bauman (2 shared papers)Alon Vitenshtein (1 shared paper)
- Journals
- mBio (3 papers)Journal of Virology (3 papers)Nature Communications (3 papers)Science Advances (2 papers)Cell Host & Microbe (2 papers)
- Partner nations
- United StatesIsraelSwitzerland
In The Last Decade
Nir Drayman
28 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 104
- Infectious Diseases 300
- Immunology 221
- Computational Theory and Mathematics 128
- Oncology 179
- Molecular Biology 462
Countries citing papers authored by Nir Drayman
This map shows the geographic impact of Nir Drayman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Drayman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Drayman more than expected).
Fields of papers citing papers by Nir Drayman
This network shows the impact of papers produced by Nir Drayman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Drayman. The network helps show where Nir Drayman may publish in the future.
Co-authors
The 25 scholars most cited alongside Nir Drayman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 197 | |
| 2 | 2011 | 147 | |
| 3 | 2022 | 130 | |
| 4 | 2019 | 105 | |
| 5 | 2022 | 101 | |
| 6 | 2012 | 83 | |
| 7 | 2019 | 51 | |
| 8 | 2021 | 46 | |
| 9 | 2013 | 45 | |
| 10 | 2019 | 32 | |
| 11 | 2021 | 29 | |
| 12 | 2017 | 24 | |
| 13 | 2010 | 23 | |
| 14 | 2016 | 22 | |
| 15 | 2022 | 22 | |
| 16 | 2016 | 18 | |
| 17 | 2011 | 15 | |
| 18 | 2009 | 13 | |
| 19 | 2016 | 13 | |
| 20 | 2024 | 11 |
About Nir Drayman
Nir Drayman is a scholar working on Epidemiology, Oncology, Immunology, Infectious Diseases and Biophysics, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (7 papers), Polyomavirus and related diseases (5 papers), Cytomegalovirus and herpesvirus research (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Plant Virus Research Studies (4 papers), Virus-based gene therapy research (4 papers), Single-cell and spatial transcriptomics (3 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Infectious Diseases (300 citations), Immunology (221 citations), Computational Theory and Mathematics (128 citations), Oncology (179 citations) and Molecular Biology (462 citations). Nir Drayman has collaborated with scholars based in United States, Israel and Switzerland. Frequent co-authors include Ariella Oppenheim, Savaş Tay, Luke F. Vistain, Veronika Butin‐Israeli, Oren Kobiler, Ofer Mandelboim, Yoav Bauman, Alon Vitenshtein, Raizy Gruda and Noam Stern‐Ginossar. Their work appears in journals such as mBio, Journal of Virology, Nature Communications, Science Advances and Cell Host & Microbe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.